Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Inclusion, Diversity, and Equity

Our Research: Equity in Discovery and Innovation

  • lab staff

  • Leaders in Equal Access to Research Innovation

    As world leaders in cancer research discovery and innovation, Dana-Farber is ever mindful that our breakthrough research — and the innovative care that results from that research — needs to be equally accessible to all patient populations, regardless of race, socioeconomics, gender, identity, veteran status, or other differentiators.

    This is why, at Dana-Farber, we are deeply committed to:

    • Growing our research in cancer disparities
    • Increasing minority representation in clinical trials
    • Integrating our research findings into clinical care and public health
  • researcher in Chowdhury Lab

    Clinical Trials

    Clinical trials are scientific studies in which new treatments – drugs, diagnostic procedures, and other therapies – are tested in patients to determine if they are safe and effective. Search ongoing clinical trials for cancer at Dana-Farber and affiliated institutions, and learn what it means to participate in a clinical trial.

  • Some of Our Cancer Disparities Research Initiatives

    Ludmila Svoboda, RN, BSN, MA, OCN, with a patient

    Cancer Care Equity Program

    This program places Dana-Farber at the forefront of efforts to reduce disparities in cancer outcomes for historically marginalized groups locally — and has become a national model for translating cancer equity research into interventions.
    lab equipment

    Initiative to Eliminate Cancer Disparities

    This initiative connects our fellow Harvard institutions to advance our commitment to reducing cancer disparities in cancer prevention, outcomes, care, and survivorship.
    prostate cancer support group participants

    Men of African Descent and Carcinoma of the Prostate Consortium

    The MADCaP Consortium is collaborating on epidemiologic studies to address the high burden of prostate cancer among men of African ancestry.
    young adult patients

    Center for Cancer Equity and Engagement

    This center works to ensure that the work and research of the Dana-Farber/Harvard Cancer Center reduces the cancer burden and inequity for all Massachusetts residents.
    pediatric doctor with a patient

    Bona Lab (Pediatric Oncology Health Equity Research)

    The mission of this lab's research is to ensure that every child diagnosed with cancer has an equal chance of survival and optimal quality of life during and after treatment.
    PROMISE Study logo

    PROMISE Study

    This study seeks to identify people with precursor conditions for multiple myeloma. African Americans are three times more likely than Caucasians to develop these conditions.